A61K 9/4808
Characterised by the form of the capsule or the structure of the
Official title: {characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084)}
A61K9/4808 (Characterised by the form of the capsule or the structure of the) appears on 1,366 US grants and 2,550 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,366
- Published applications
- 2,550
- Assignees
- 850
- Inventors
- 3,307
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 8 | 0 |
| 1995 | 13 | 0 |
| 1996 | 8 | 0 |
| 1997 | 15 | 0 |
| 1998 | 10 | 0 |
| 1999 | 10 | 0 |
| 2000 | 14 | 0 |
| 2001 | 18 | 3 |
| 2002 | 11 | 22 |
| 2003 | 19 | 51 |
| 2004 | 12 | 40 |
| 2005 | 7 | 52 |
| 2006 | 10 | 56 |
| 2007 | 9 | 58 |
| 2008 | 11 | 64 |
| 2009 | 11 | 64 |
| 2010 | 33 | 81 |
| 2011 | 20 | 95 |
| 2012 | 39 | 79 |
| 2013 | 63 | 101 |
| 2014 | 71 | 171 |
| 2015 | 77 | 189 |
| 2016 | 111 | 196 |
| 2017 | 94 | 188 |
| 2018 | 89 | 147 |
| 2019 | 83 | 162 |
| 2020 | 93 | 172 |
| 2021 | 82 | 125 |
| 2022 | 82 | 108 |
| 2023 | 62 | 97 |
| 2024 | 70 | 105 |
| 2025 | 45 | 84 |
| 2026 | 35 | 40 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of reducing food intake in a healthy mammal25 Aug 2026US 12,714,665 B2Teagasc, The Agriculture and Food Development Authority
- Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same25 Aug 2026US 12,714,730 B2Persephone Biosciences, Inc.
- Capsule device with an aperture formed by an overlap of two halve-capsule shells4 Aug 2026US 12,697,284 B2EsoCap AG
- Microparticles containing stabilized CBD oil, and methods for the production thereof4 Aug 2026US 12,697,345 B2Anabio Technologies Limited
- Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof28 Jul 2026US 12,691,074 B2Impax Laboratories, LLC
- Sleep formulation1 Oct 2026US 2026/0294816 A1NightWise, LLC
- Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof1 Oct 2026US 2026/0294817 A1Impax Laboratories, LLC
- Aqueous partitioning capsules17 Sep 2026US 2026/0272845 A1Kansas State University Research Foundation
- Ingestible device for delivery of therapeutic agent to the gastrointestinal tract27 Aug 2026US 2026/0249061 A1
- Pharmaceutical dosage form for application to mucous membranes and methods for producing same20 Aug 2026US 2026/0240783 A1EsoCap AG
Most cited
By later US patents
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001
- Clear oil-containing pharmaceutical compositions437US 6,267,985 B1Lipocine Inc. · 2001
- Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level410US 5,478,577 AEuroceltique, S.A. · 1995
- Method of treating pain by administering 24 hour oral opioid formulations401US 5,672,360 APurdue Pharma L. P. · 1997
- Tamper-resistant oral opioid agonist formulations343US 6,696,088 B2Euro-Celtique S. A. · 2004